Regents of the University of California v. Eli Lilly & Co.
Court of Appeals for the Federal Circuit
119 F.3d 1559 (1997)
- Written by Craig Conway, LLM
Facts
Regents of the University of California (UC) (plaintiff) sued Eli Lilly (defendant) for infringing the ‘525 patent, which claimed a gene sequence used in manufacturing human insulin. Human insulin consists of two amino acid chains, referred to as A and B. UC disclosed amino acid chains A and B in the specification, as well as methods of creating cDNA that codes for, or makes, the desired insulin. UC claimed a variety of microorganisms containing the cDNA, but only disclosed rat cDNA in the specification. Eli Lilly argued in defense that the claims were invalid for failing to meet the written description requirement under 35 U.S.C. §112, ¶1. After a bench trial, the judge ruled in favor of Eli Lilly and held the patent claims invalid, which UC appealed.
Rule of Law
Issue
Holding and Reasoning (Lourie, C.J.)
What to do next…
Here's why 802,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.